close

Biolab's corporate governance is an example of good business practices focused on transparency, ethics and responsibility. With the creation of an Advisory Board made up of independent members and industry experts, the company has promoted more efficient management in line with international best practices. In 2023, Biolab strengthened its governance structure, with a focus on empowering its leaders and improving strategic decision-making to ensure the company's sustainable growth.

The company has implemented a strict compliance program, with anti-corruption policies and a code of ethical conduct that guides all its operations. Risk management has also been improved, following standards such as ISO 31000 and COSO ERM, which guarantee the identification, mitigation and continuous monitoring of operational and financial risks. Biolab is committed to integrity and transparency, promoting responsible business practices that strengthen the trust of its stakeholders.

Governance is also expanding into the field of diversity and inclusion. In 2023, the company reached an important milestone, with 41% of leadership positions held by women, reinforcing its commitment to gender equity and representativeness at all levels of the organization. Biolab's ombudsman channel, which guarantees the anonymity of whistleblowers, reflects the company's ongoing effort to maintain an ethical environment where all employees can safely report inappropriate practices.

With this robust structure, Biolab positions itself as a leading company in corporate governance, ensuring that its operations are aligned with the values of ethics, transparency and sustainability.

Ethics and compliance

Biolab is committed to conducting its business with ethics, integrity and transparency, in full compliance with the law, including the Brazilian Anti-Corruption Law. The Company does not tolerate bribery, corruption, fraud, harassment or any behavior contrary to the ethical values set out in the Code of Ethical Conduct.

Risk management

Biolab is focused on projects to improve its process guidelines and strengthen its risk management culture. The Company's Corporate Risk Management Policy aims to establish clear guidelines and define precise responsibilities in business processes and among managers.

Advisory Board

The Advisory Board is the central body of the corporate governance system, exercising its duties with a focus on the company's long-term interests and safeguarding its values. The Board is committed to recommending actions that benefit the Company and its processes, with an emphasis on the Organization's core themes: people; performance; risks; strategy; and innovation.

Biolab Process Management (BPM)

BPM was created to standardize and systematize internal processes and their documents in order to streamline the flow of day-to-day activities. BPM works towards results, more effective management (by institutionalizing documents and standardizing processes), continuous improvement and integration between areas.

Main Cover of the Report - EN

Check out Sustainability Report 2023/2024 complete

 

See also:

Copyright © Biolab | Rights Reserved - 2024